SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-048020
Filing Date
2014-07-17
Accepted
2014-07-17 20:48:16
Documents
1
Period of Report
2014-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3907
  Complete submission text file 0001209191-14-048020.txt   5529
Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Issuer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
Business Address
Hunter William L (Reporting) CIK: 0001432062 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51171 | Film No.: 14981559